Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma
Leuk Lymphoma
.
2022 Nov;63(11):2739-2742.
doi: 10.1080/10428194.2022.2087071.
Epub 2022 Jun 24.
Authors
Manik Chahal
1
,
Anna Hayden
2
,
Kerry J Savage
1
,
Diego Villa
1
,
David W Scott
1
,
Alina S Gerrie
1
,
Andrea Lo
3
,
Matthew Chan
3
,
Tom Pickles
3
,
Joseph M Connors
1
,
Laurie Helen Sehn
1
,
Ciara L Freeman
1
4
Affiliations
1
Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer and the University of British Columbia, Vancouver, Canada.
2
BC Cancer Fraser Valley, Surrey, Canada.
3
Division of Radiation Oncology, BC Cancer, Vancouver, Canada.
4
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
PMID:
35749607
DOI:
10.1080/10428194.2022.2087071
No abstract available
Publication types
Letter
MeSH terms
Hodgkin Disease* / diagnosis
Hodgkin Disease* / pathology
Hodgkin Disease* / therapy
Humans